Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma. - Shaikh SS; Zang Y; Hanmer J; Wang H; Lin Y; Davar D; Zarour HM; Kirkwood JM; Najjar YG (Frontiers in oncology, 2022)